Broadcom Introduces New Server Network Virtualization Acceleration Technology for VXLAN Cloud-Scale Networks

Press release from Broadcom:

Broadcom Introduces New Server Network Virtualization Acceleration Technology for VXLAN Cloud-Scale Networks

Industry's Most Complete End-to-End Platform Solution Improves Server Performance by More than 55 Percent(1)

SAN FRANCISCO, Aug. 28, 2012 /PRNewswire/ --

News Highlights:

• Most complete portfolio of controller and switch solutions for VXLAN cloud-scale networks
• Delivers advanced functionality needed for large scale VXLAN multi-tenant network deployment
• Enables enhanced scaling for large scale network deployment                            

Broadcom Corporation (NASDAQ: BRCM), a global innovation leader in semiconductor solutions for wired and wireless communications, today announced its NetXtreme^® II server network virtualization (NV) acceleration technology for VXLAN implementations, improving server performance by more than 55 percent. Together with Broadcom's new StrataXGS^®Trident II Switch Series with Smart NV technology, Broadcom offers the industry's most complete end-to-end platform solution for VXLAN cloud-scale networks. Visit www.broadcom.com to learn more.

Virtualized cloud-scale networks with multiple tenants are growing at unprecedented rates while exceeding the limits of existing network architectures. VXLAN innovation addresses this need by decoupling the physical and logical address space through the creation of overlay networks. Broadcom has revolutionized the ability to scale multi-tenant networks with VXLAN, enabling logical, software-based networks that can be created on demand and increase the scale of virtual machines on the physical server while maintaining Quality of Service (QoS).

Through VMware's collaboration with Broadcom and other leading ecosystem vendors, VXLANs are expected to become the default standard for multi-tenant cloud-scale networks. With the industry's most complete portfolio of solutions optimized for VXLAN, Broadcom has broken through traditional silicon and software barriers to enable the fast, fat and flat virtualized network required for true scalability in next generation cloud-scale networks.

About the Broadcom NetXtreme Portfolio

Broadcom's NetXtreme Ethernet solutions improve virtualization by converging data and storage networks on a common 10GbE fabric. Broadcom NetXtreme Ethernet adapters deliver line rate throughput that is 37 percent faster than the nearest converged network adapter (CNA) competitor, together with full support of iSCSI and FCoE offload storage protocols, capable of delivering up to 1.5 million iSCSI input/output operations per second (IOPS), or 2.5 million FCoE IOPS with superior CPU efficiency².

Availability

Broadcom's server network virtualization acceleration technology is now sampling. Broadcom NetXtreme II Ethernet solutions are currently shipping with multiple top tier OEM servers — including Dell PowerEdge 12^th Generation, HP ProLiant Gen8, IBM, Cisco, NEC and Hitachi.

Broadcom will demonstrate its full line of solutions for VXLAN at VMworld^® 2012, August 26 - 30 in San Francisco's Moscone Center, booth #2107.

For ongoing Broadcom news visit our Newsroom, read our B-Connected Blog, or visit us on Facebook or Twitter. And to stay connected, subscribe to our RSS Feed.

Quotes:

Allwyn Sequeira, Vice President and CTO, Networking and Security, VMware

"With broad support by companies such as Broadcom, we are pleased to see organizations use VXLAN-based solutions to take advantage of new levels of data center automation, agility, and efficiency. The end-to-end solutions that Broadcom is offering with both controller and switch support for VXLAN creates great value for cloud operators deploying virtualized multi-tenant networks."

Brian Payne, Executive Director, PowerEdge Servers, Dell

"As a long-standing technology partner, Dell is collaborating with Broadcom on support for VXLAN environments to enable breakthrough scalability for customers who need it. Dell is meeting the challenges customers face in architecting and deploying next generation and virtualized data centers with the support of technologies like Broadcom's new server network virtualization acceleration technology."

McLeod Glass, Director of Mainstream Systems Marketing, Industry Standards Servers, HP

"Data center managers leveraging VXLAN technology are seeking to lower CAPEX costs while increasing network performance for cloud computing. Combining Broadcom NetXtreme II controllers with HP ProLiant Gen8 servers enable customers to lower costs by leveraging their existing resources more efficiently through increased scalability and network performance."

Rohit Mehra, Director of Enterprise Communications Infrastructure, IDC

"The deployment of flexible networking solutions and architectures such as VXLAN is expected to accelerate the adoption of multi-tenant cloud solutions. Broadcom's collaboration with other ecosystem partners to draft and standardize the VXLAN specification, as well as their investment in new technologies to accelerate the performance of VXLAN implementations demonstrates their strong commitment to the cloud market."

Vinod Lakhani, General Manager, High Speed Controllers, Broadcom Corporation

"Through our collaboration with VMware and other partners, we were provided with the unique opportunity to co-author and standardize VXLAN implementation and leverage this knowledge to enhance innovation throughout our portfolio. Cloud and enterprise IT architects can now leverage the combination of VXLAN and Broadcom's complete portfolio of NetXtreme controllers and StrataXGS switch technologies to increase performance and reduce total cost of ownership."

Resources: 
¹ Based on Broadcom independent testing of Server NV Acceleration technology on VXLAN
² Demartek Performance Report
NetXtreme Enterprise Adapters Feature Page 
NetXtreme Ethernet Solutions for Dell
NetXtreme Ethernet Solutions for HP
ESG: Broadcom Delivers NetXtreme Performance

About Broadcom

Broadcom Corporation (NASDAQ: BRCM), a FORTUNE 500® company, is a global leader and innovator in semiconductor solutions for wired and wireless communications. Broadcom® products seamlessly deliver voice, video, data and multimedia connectivity in the home, office and mobile environments.  With the industry's broadest portfolio of state-of-the-art system-on-a-chip and embedded software solutions, Broadcom is changing the world by connecting everything®.  For more information, go to www.broadcom.com.

GE & Partners Announce Winners of the First Stage of $100 M "healthymagination Cancer Challenge"

Press release:

27 March 2012

GE & Partners Announce Winners of the First Stage of $100 Million “healthymagination Cancer Challenge”

· Challenge focused on early-stage breast cancer breakthroughs that warrant discovery, incubation and acceleration through seed funding

· Winning innovations could expedite breast cancer detection, diagnosis and improve the identification of effective therapies, allowing more patients to survive

SAN FRANCISCO--27 March 2012-- GE (NYSE: GE) announced today five innovation award winners as part of the first stage of its $100 million “GE healthymagination Cancer Challenge.” More than 500 ideas from 40 countries were submitted, sparking robust conversations among more than 200 academic institutions and researchers on the Challenge’s open innovation platform.

The five innovation award winners have the potential to help doctors find cancer earlier, make more accurate diagnoses and choose the best possible treatment based on each patient’s unique cancer. The submitted ideas include ones that could help doctors better understand the molecular similarities between breast cancer and other solid tumors with a particular focus on tumors associated with triple negative cancer, a type of cancer that is less responsive to standard treatments and is typically more aggressive. GE is committed to a new approach at healthymagination that shines a spotlight on early-stage ideas to accelerate the researchers’ work and ultimately help patients sooner.

Beth Comstock, senior vice president and chief marketing officer, GE said, “We launched the Challenge as a call to action for oncology researchers, businesses, and other innovators around the world to accelerate innovation and help stop this deadly disease. It is often challenging for early stage research to grab the attention of seed investors. The Challenge has shown us that there are a remarkable number of breakthrough ideas out there that deserve promotion, investment and incubation.”

In addition to the $100,000 seed award, GE will provide support for each winner through mentorship and access to GE researchers and industry thought leaders with opportunity for expanded partnerships in the future.

“GE and Clarient focus on helping health providers understand and define the drivers of a patient’s particular cancer. The Challenge winners' work will change the future of fighting cancer,” said Carrie Eglinton-Manner, general manager of Clarient, the cancer diagnostics company acquired by GE in 2010. “In addition to the grant money, we will help mentor, develop and accelerate the growth of these winning ideas.”

The winners were selected by a panel of judges that included venture capital partners, GE executives, and several leading healthcare luminaries including former U.S. FDA Commissioner and National Cancer Institute Director, Dr. Andrew Von Eschenbach; Professor of Surgery and Director of the University of Michigan Breast Care Center, Dr. Lisa Newman; and cancer medicine specialist and Imperial College’s professor of cancer medicine, Dr. Justin Stebbing.

The five innovation Challenge award winners are:

• MyCancerGenome- Personalized Approach to Triple Negative Breast Cancer: Vanderbilt University in Nashville, Tennessee is developing MyCancerGenome, a free online cancer medicine resource and decision-making tool for physicians, patients, caregivers and researchers. It provides up-to-date information on what mutations make breast cancer grow and related treatment implications, including available genome-directed clinical trials for triple negative breast cancer.
• Creating Safer & Stronger Breast Implants with Cancer-fighting and Healing Properties: The University of Akron in Akron, Ohio is developing new materials for breast reconstruction to transform tissue expanders and implants into cancer-fighting and healing devices. Using coatings embedded with pharmaceutical agents the new device is expected to help fight infection, reduce inflammation, and possibly even target and destroy stray cancer cells.
• Identifying a Predisposition to Cancer Spread: Moffitt Cancer Center in Tampa, Florida is working to understand the genetic "modifier" genes and their role in predisposition to the spread of cancer to other parts of the body following cancer onset. This research could form the basis of diagnostic testing for genes that place a patient at disproportionate risk for cancer spread and guide aggressiveness of treatment.
• Saving Lives in Developing Countries: For developing countries such as Uganda, breast ultrasound holds promise in identifying cancers in young women with palpable lumps. Fred Hutchinson Cancer Research Center in Seattle, Washington and Uganda Cancer Institute (UCI) in Kampala are establishing a breast cancer screening program where women will receive education about breast cancer and those with symptoms will be offered clinical breast exam and breast ultrasound. Women with suspicious lumps will be referred to the UCI for tissue sampling and, if malignancy is diagnosed, treatment.
• Moving to Personalized Therapy for Triple Negative Breast Cancer: Researchers at Vanderbilt-Ingram Cancer Center in Nashville, Tennessee have demonstrated that gene expression analysis reveals at least six distinct disease subtypes for triple negative breast cancer that likely respond differently to chemotherapy. Using this discovery, the Center is designing clinical trials with targeted therapy for select subtypes which will soon be offered to patients.

Information on the winners is available at www.healthymagination.com.

Launched in September, the Challenge is part of GE’s healthymagination commitment to accelerate cancer innovation by investing $1 billion in cancer technology research and development as well as improve care for 10 million cancer patients around the world by 2020. Additional strategic commercial partnership announcements from the Challenge will be made later in 2012. For additional details on the challenge, and to view the full terms and conditions visit healthymagination.com/challenge.

About GE

GE (NYSE: GE) works on things that matter. The best people and the best technologies taking on the toughest challenges. Finding solutions in energy, health and home, transportation and finance. Building, powering, moving and helping to cure the world. Not just imagining. Doing. GE works. For more information, visit the company's website at www.ge.com.

About GE’s healthymagination Initiative

Launched in May 2009, GE’s healthymagination initiative is focused on four critical needs: low-cost technology; healthcare IT; innovation accessible to all; and consumer-driven healthcare. GE has committed that by 2015 it will:

• Invest $3 billion in research and development to launch at least 100 innovations that will help deliver better care to more people at lower cost.
• Provide $2 billion in financing and $1 billion in technology to bring healthcare information technology to rural and underserved areas.
• Reduce the cost of procedures that use GE technologies and services by 15 percent and develop products tailored to underserved regions of the world.
• Reach 100 million more people every year with services and technologies essential for health.

More information at www.healthymagination.com.